Imed Infinity Medical-Limited Partnership reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 1.01 million compared to USD 0.766 million a year ago. Basic loss per share from continuing operations was USD 0.25 compared to USD 0.19 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
95.2 ILa | 0.00% | +0.53% | -16.64% |
1st Jan change | Capi. | |
---|---|---|
-16.64% | 1.02M | |
+23.89% | 83.59B | |
+9.80% | 17.41B | |
+58.32% | 16.75B | |
+8.97% | 14.63B | |
-3.87% | 12.32B | |
+10.13% | 11.34B | |
-0.70% | 10.9B | |
+94.30% | 9.88B | |
+28.43% | 9.85B |
- Stock Market
- Equities
- IMED Stock
- News Imed Infinity Medical-Limited Partnership
- Imed Infinity Medical-Limited Partnership Reports Earnings Results for the Full Year Ended December 31, 2022